z-logo
open-access-imgOpen Access
In Silico Molecular Interaction Studies of Suberoylanilide Hydroxamic Acid and Its Modified Compounds with Histones Deacetylase Class II <i>Homo sapiens</i> as Curative Measure towards Cervical Cancer
Author(s) -
Usman Sumo Friend Tambunan,
Arli Aditya Parikesit,
Tirtana Prasetia,
Djati Kerami
Publication year - 2013
Publication title -
engineering
Language(s) - English
Resource type - Journals
eISSN - 1947-3931
pISSN - 1947-394X
DOI - 10.4236/eng.2013.510b043
Subject(s) - hdac1 , histone deacetylase , in silico , histone , chemistry , drug , docking (animal) , pharmacology , medicine , biochemistry , gene , nursing
The threat of cervical cancer is a serious problem for the women’s health. It is already known that the cause of cervical cancer is definitely HPV (Human Papilloma Virus). The drug development is the most reasonable approach for coping with HPV infection. The development of HDACi (Histone Deacetylase inhibitor) is seen as a feasible method for curing the threat of cervical cancer. Rational drug design is our utilized pipeline for drug development. The LigX MOE-based method has been developed to investigate the molecular interaction of HDAC class II Homo sapiens with the designed lead compound. The method has found that ligands 1c, 2a, and 2c are indeed feasible to be formulated as drug candidates.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom